Theriva Biologics, Inc. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
Theriva Biologics, Inc. (TOVX) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-16.
Discontinued › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2022-03-16
- Theriva Biologics, Inc. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2021 was $0.00.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |